Hoffmann-La Roche, a pharmaceutical industry giant, enjoyed a tasty chunk of good news this month. Their friends at the ever-cooperative FDA have allowed them to bring a milder version of their prescription fat-blocking drug, Xenical, to the over-the-counter market this summer. The new OTC drug is called alli.